Search details
1.
Second-line chemoimmunotherapy with nivolumab and paclitaxel in immune-related biomarker-enriched advanced gastric cancer: a multicenter phase Ib/II study.
Gastric Cancer
; 27(1): 118-130, 2024 Jan.
Article
in English
| MEDLINE | ID: mdl-37906316
2.
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first-line treatment for advanced or metastatic oesophageal squamous cell carcinoma (RATIONALE-306): a global, randomised, placebo-controlled, phase 3 study.
Lancet Oncol
; 24(5): 483-495, 2023 05.
Article
in English
| MEDLINE | ID: mdl-37080222
3.
Combination therapy with pazopanib and tivantinib modulates VEGF and c-MET levels in refractory advanced solid tumors.
Invest New Drugs
; 39(6): 1577-1586, 2021 12.
Article
in English
| MEDLINE | ID: mdl-34180036
4.
Role of palliative radiotherapy in bleeding control in patients with unresectable advanced gastric cancer.
BMC Cancer
; 21(1): 413, 2021 Apr 15.
Article
in English
| MEDLINE | ID: mdl-33858353
5.
Clinical outcomes of systemic therapy in patients with unresectable or metastatic combined hepatocellular-cholangiocarcinoma.
Liver Int
; 41(6): 1398-1408, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33548073
6.
Multicenter phase III trial of S-1 and cisplatin versus S-1 and oxaliplatin combination chemotherapy for first-line treatment of advanced gastric cancer (SOPP trial).
Gastric Cancer
; 24(1): 156-167, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-32596783
7.
Systemic Steroid Treatment for Imatinib-Associated Severe Skin Rash in Patients with Gastrointestinal Stromal Tumor: A Phase II Study.
Oncologist
; 25(11): e1785-e1793, 2020 11.
Article
in English
| MEDLINE | ID: mdl-32589310
8.
How Cancer Patients Perceive Clinical Trials (CTs) in the Era of CTs: Current Perception and Its Differences Between Common and Rare Cancers.
J Cancer Educ
; 35(3): 545-556, 2020 06.
Article
in English
| MEDLINE | ID: mdl-30820925
9.
Genome-wide copy number alteration and VEGFA amplification of circulating cell-free DNA as a biomarker in advanced hepatocellular carcinoma patients treated with Sorafenib.
BMC Cancer
; 19(1): 292, 2019 Apr 01.
Article
in English
| MEDLINE | ID: mdl-30935424
10.
Loss of HER2 positivity after anti-HER2 chemotherapy in HER2-positive gastric cancer patients: results of the GASTric cancer HER2 reassessment study 3 (GASTHER3).
Gastric Cancer
; 22(3): 527-535, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30386954
11.
A randomized phase II study of S-1 versus capecitabine as first-line chemotherapy in elderly metastatic gastric cancer patients with or without poor performance status: clinical and pharmacogenetic results.
Pharmacogenet Genomics
; 28(1): 23-30, 2018 Jan.
Article
in English
| MEDLINE | ID: mdl-29189588
12.
Nomograms predicting survival of patients with unresectable or metastatic gastric cancer who receive combination cytotoxic chemotherapy as first-line treatment.
Gastric Cancer
; 21(3): 453-463, 2018 May.
Article
in English
| MEDLINE | ID: mdl-28828688
13.
Phase II study of oxaliplatin, irinotecan and S-1 therapy in patients with advanced gastric cancer: the Korean Cancer Study Group ST14-11.
Gastric Cancer
; 21(5): 802-810, 2018 09.
Article
in English
| MEDLINE | ID: mdl-29372461
14.
Novel endoscopic categorization for prediction of chemoradiotherapy response in locally advanced esophageal cancer.
J Gastroenterol Hepatol
; 33(6): 1213-1219, 2018 Jun.
Article
in English
| MEDLINE | ID: mdl-29193280
15.
Phase II study of neoadjuvant imatinib in large gastrointestinal stromal tumours of the stomach.
Br J Cancer
; 117(1): 25-32, 2017 Jun 27.
Article
in English
| MEDLINE | ID: mdl-28535156
16.
A Phase I/IIa Study of DHP107, a Novel Oral Paclitaxel Formulation, in Patients with Advanced Solid Tumors or Gastric Cancer.
Oncologist
; 22(2): 129-e8, 2017 02.
Article
in English
| MEDLINE | ID: mdl-28196905
17.
Efficacy and Safety of FOLFIRI Regimen in Elderly Versus Nonelderly Patients with Metastatic Colorectal or Gastric Cancer.
Oncologist
; 22(3): 293-303, 2017 03.
Article
in English
| MEDLINE | ID: mdl-28209749
18.
Associations between CYP2A6 polymorphisms and outcomes of adjuvant S-1 chemotherapy in patients with curatively resected gastric cancer.
Gastric Cancer
; 20(1): 146-155, 2017 Jan.
Article
in English
| MEDLINE | ID: mdl-26715117
19.
Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB-IV gastric cancer.
Gastric Cancer
; 20(1): 182-189, 2017 Jan.
Article
in English
| MEDLINE | ID: mdl-26661592
20.
Phase I/II study of a combination of capecitabine, cisplatin, and intraperitoneal docetaxel (XP ID) in advanced gastric cancer patients with peritoneal metastasis.
Gastric Cancer
; 20(6): 970-977, 2017 Nov.
Article
in English
| MEDLINE | ID: mdl-28303362